[HTML][HTML] Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses
S Jiang, C Hillyer, L Du - Trends in immunology, 2020 - cell.com
S Jiang, C Hillyer, L Du
Trends in immunology, 2020•cell.comCoronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social
stability, and economic development. To meet this challenge, this article discusses
advances in the research and development of neutralizing antibodies (nAbs) for the
prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
(SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social
stability, and economic development. To meet this challenge, this article discusses
advances in the research and development of neutralizing antibodies (nAbs) for the
prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
cell.com
